Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225.4 USD | +1.43% |
|
+1.35% | +9.74% |
09/07 | Baird Adjusts Cencora's Price Target to $285 From $280, Keeps Outperform Rating | MT |
09/07 | TD Cowen Adjusts Cencora's Price Target to $271 From $265, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.74% | 44.38B | |
-6.68% | 179B | |
-5.20% | 100B | |
-5.38% | 66.67B | |
+18.16% | 44.81B | |
-6.47% | 46.16B | |
+14.01% | 29.53B | |
+22.31% | 25.83B | |
-6.53% | 23.97B | |
-11.70% | 22.11B |
- Stock Market
- Equities
- COR Stock
- News Cencora, Inc.
- Transcript : AmerisourceBergen Corporation Presents at Goldman Sachs 12th Annual Healthcare CEOs Unscripted